Loading

Archive for the 'Pharma' Category

All information about Pharma, Pharma Latest News

How will Novartis finance Alcon buy?

Last week, we reported that analysts are expecting Novartis to follow through on its deal to buy the rest of

J&J expands Tylenol Arthritis recall

Drugmakers have been diversifying quite a bit lately, diving

Ranbaxy offloads Chinese venture stake

While much of Big Pharma races toward China, Ranbaxy Laboratories is taking one step out of that market. The Indian company has sold its stake in a Chinese joint venture, saying it will continue to market drugs in China–albeit drugs made outside the country. It was Ranbaxy’s second sale…

Caterpillar aims to curtail drug costs

In a move that outlines the growing influence of employers and insurers on drug-buying, heavy equipment maker

A look back at Pharma in 2009

So much has changed this year that it’s hard to believe January 1, 2009 was almost 12 months ago. President Obama took office, bringing new leadership for the FDA

Sanofi said to drop out of Ratiopharm race

Sanofi-Aventis dropped its bid for the German generics maker Ratiopharm in favor of deals for companies bringing new products to the table or offering access to new markets, Bloomberg reports.

New year, new administration, new FDA

The new year brought a new U.S. administration, and it wasn’t long before word was out: Dr. Margaret Hamburg, former New York City Health Commissioner, would lead the agency; Dr. Joshua Sharfstein, Baltimore Health Commissioner, would be her deputy numero uno. Even more quickly off the mark was Congress,…

Flu pandemic a big boon–and a bit bust

Hard to believe, but the H1N1 “swine” flu pandemic only hit the public consciousness this past spring. That was when Mexico first announced it had toted up dozens of cases. And it wasn’t till April 30 that the World Health Organization officially declared a pandemic. Of course, we’ve read…

Pharma front-and-center on healthcare reform

When President Obama took office, pharma had already been hard at work lobbying for their point of view on healthcare reform. After all, the new president had said repeatedly that reforming healthcare was his top priority. The trade group PhRMA, the association of generics makers, BIO, and individual companies…

Pharma layoffs cut deep, spread widely

The roll call of pharma companies that laid off workers this year certainly reads like an industry who’s who. Johnson & Johnson. Pfizer, both pre-Wyeth-merger and post-merger. Merck, ditto. GlaxoSmithKline. Sanofi-Aventis. AstraZeneca. Lots of those jobs lost were sales-rep posts